AVP deficiency is considered a rare disease, with an estimated prevalence in the population of approximately 1 in 25,000 individuals, and it belongs to the polyuria-polydipsia syndrome, along with AVP resistance (nephrogenic diabetes insipidus) and primary polydipsia [1, 5]. The gene discussed is AVP; the disease is neurohypophyseal diabetes insipidus.